Medicare AdvantageCoverageMedium impact
MA00.005as, Experimental/Investigational Services
Independence Blue Cross·Medical Policy
Effective date
Apr 1, 2026
We identified it
Jun 19, 2026
Summary
Policy MA00.005as establishes coverage and reimbursement guidelines for experimental and investigational services under Medicare Advantage plans, effective April 1, 2026. This recent policy change affects how claims for investigational procedures and treatments are processed and paid. The billing team must understand the new criteria for coverage determination and prior authorization requirements for these services.
Action Required
By March 31, 2026: Billing team must review the full text of policy MA00.005as to identify specific experimental/investigational services covered or excluded under Medicare Advantage plans. Update billing software and claim submission protocols to reflect new coverage criteria. Establish process for obtaining prior authorization for experimental services before claim submission. Train billing staff and providers on the new guidelines. Communicate policy changes to clinical staff who order investigational procedures. Without proper implementation, claims for experimental/investigational services will be denied or processed incorrectly.